Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-04	Wendy Wang, Ph.D., M.Sc.
Herrmann, Joerg	Mayo Clinic Rochester United States	TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial	5R01CA233610-06	Eileen Dimond, R.N., M.S.
Hilakivi-Clarke, Leena A.	University Of Minnesota United States	Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota	5R01CA276775-03	Amit Kumar, Ph.D.
Hill, Joshua Aiden	Fred Hutchinson Cancer Center United States	Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy	5R01CA276040-03	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hitchins, Megan P	H. Lee Moffitt Cancer Ctr & Res Inst United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	7R01CA252042-05	Matthew Young, Ph.D.
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-09	Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	4U01CA288375-03	Sidney Fu, M.D.
Howitt, Brooke E	Stanford University United States	Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping	1R37CA303960-01	Goli Samimi, Ph.D., M.P.H.
Hruska, Carrie B	Mayo Clinic Rochester United States	Density MATTERS Clinical Trial	5R01CA239200-05	Claire Zhu, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01	Claire Zhu, Ph.D.
Hu, Jim	Weill Medical Coll Of Cornell Univ United States	Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)	5R01CA259173-04	Marjorie Perloff, M.D.
Hu, Shuiying	Ohio State University United States	Targeting neuronal transport to ameliorate vincristine neurotoxicity	5R01CA272254-03	Rachel Altshuler, Ph.D.
Huang, Ying	Western University Of Health Sciences United States	Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol	5R01CA269653-04	Anda Vlad, M.D., Ph.D.
Huang, Yijian	Emory University United States	Analytic diagnosis methods for disease ruling	5R01CA283687-02	Guillermo Marquez, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-03	Matthew Young, Ph.D.